drugset / Trial / NCT01693718

A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer

NCT01693718

Phase 2 Completed 44 enrolled University of Chicago
NaSingle-groupOpen-labelTreatment

Summary

The goal of the study is to test a particular combination of drugs and determine their ability to completely eliminate head and neck cancer.

Timeline

Start
2003-03
Primary completion
2003-09
Completion
2004-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 100 mg/m2 Intravenous
Subject Hydroxyurea Other / unclassified 1 g Oral
Subject fluorouracil Small molecule 800 mg/m2

Indications